23andMe Holding Co. ME:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/07/24 EDT
0.48quote price arrow down-0.0135 (-2.713%)
Volume
9,620
Close
0.4976UNCH (UNCH)
Volume
3,190,140
52 week range
0.35 - 2.21
Loading...
  • Open0.48
  • Day High0.5073
  • Day Low0.4761
  • Prev Close0.4866
  • 52 Week High2.21
  • 52 Week High Date05/10/23
  • 52 Week Low0.35
  • 52 Week Low Date04/17/24

Key Stats

  • Market Cap240.299M
  • Shares Out482.92M
  • 10 Day Average Volume3.37M
  • Dividend-
  • Dividend Yield-
  • Beta1.24
  • YTD % Change-45.53

KEY STATS

  • Open0.48
  • Day High0.5073
  • Day Low0.4761
  • Prev Close0.4866
  • 52 Week High2.21
  • 52 Week High Date05/10/23
  • 52 Week Low0.35
  • 52 Week Low Date04/17/24
  • Market Cap240.299M
  • Shares Out482.92M
  • 10 Day Average Volume3.37M
  • Dividend-
  • Dividend Yield-
  • Beta1.24
  • YTD % Change-45.53

RATIOS/PROFITABILITY

  • EPS (TTM)-1.11
  • P/E (TTM)-0.45
  • Fwd P/E (NTM)-0.74
  • EBITDA (TTM)-296.838M
  • ROE (TTM)-92.53%
  • Revenue (TTM)247.987M
  • Gross Margin (TTM)45.30%
  • Net Margin (TTM)-210.48%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/26/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On 23andMe Holding Co.

Profile

MORE
23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including information on customers’ genetic ancestral origins, personal genetic health risks, and...
Anne Wojcicki
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Joseph Selsavage
Interim Chief Financial Officer, Chief Accounting Officer
Guy Chayoun
General Counsel, Corporate Secretary
Address
349 Oyster Point Boulevard
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
CHRS
Coherus BioSciences Inc
2.25UNCHUNCH
PBYI
Puma Biotechnology Inc
4.75UNCHUNCH
RVNC
Revance Therapeutics Inc
4.38UNCHUNCH
AKBA
Akebia Therapeutics Inc
1.40UNCHUNCH
XERS
Xeris Biopharma Holdings Inc
1.88UNCHUNCH